acyclovir sodium recall (Fresenius Kabi Compounding, LLC)
DrugClass IIOngoing
Summary: Fresenius Kabi Compounding, LLC is recalling acyclovir sodium, 200 mg, 200mg added to 100 mL, 0.9% Sodium Chloride Injection, USP, For Intravenous Use, Single-Use Bag, Fagron Sterile Services, 20 Dan Road, Canton, MA 02021, NDC 71506-035-56. Reason: Lack of Assurance of Sterility.
What is being recalled
acyclovir sodium, 200 mg, 200mg added to 100 mL, 0.9% Sodium Chloride Injection, USP, For Intravenous Use, Single-Use Bag, Fagron Sterile Services, 20 Dan Road, Canton, MA 02021, NDC 71506-035-56
Why
Lack of Assurance of Sterility
How serious is it
Class II is the middle level: using or being exposed to this product may cause temporary or medically reversible health problems, and the chance of serious harm is remote.
Where it was sold
US Nationwide.
How to tell if yours is affected
Lot # C274-000049124, Exp Date: 28-Feb-26.
What to do
Check the product name, lot number and expiration date on your package against the codes above. If they match, do not stop taking a prescription medicine without talking to your doctor or pharmacist first; ask them about a replacement. Return or dispose of the product as your pharmacy advises.
Recall facts
| Recall number | D-0333-2026 |
| Category | Drug |
| Agency | U.S. Food and Drug Administration (FDA) |
| Severity | Class II |
| Status | Ongoing |
| Recall started | February 5, 2026 |
| Reported | February 18, 2026 |
| Company | Fresenius Kabi Compounding, LLC |
| Company location | Canton, MA, United States |
| Initiated by | Voluntary: Firm initiated |
| Quantity | 1057 bags |
More recalls from Fresenius Kabi Compounding, LLC · all drug recalls · recalls from February 2026